SEC Form D private-offering filing
Pearl Diagnostics, Inc.
A new SEC Form D private-offering notice from Baltimore, MD, a $11,150,000 filer-stated offering target in Biotech. The source filing is one click away.
Develops in vitro diagnostic tests for early detection of lung infections, including the MycoMEIA Aspergillus Assay.
Filed 2026-04-21Filed to raise $11,150,000First money in 2026-03-19Raised so far $11,150,000HQ (as filed) Baltimore, MDSector Biotech ✓Stage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified pearldx.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.